ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q3SCImago #17,535Gold OA

Advances in Urology

Identifier (ISSN):1687-6369(Print)/1687-6377(Online)
•
Publisher:Hindawi Limited
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
0.6↓ -1.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Advances in Urology

WoS Q4
01231.420231.820242.320250.62026
Annual Impact Factor Metric
Current (2026):0.6
Scopus SJR & RankScopus Q3
0.29
#17,535

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
42

42 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
14articles/year
100% Gold OA•80% Original Research

Aims & Scope

Advances in Urology is a peer-reviewed, open access journal that publishes state-of-the-art reviews and original research papers of wide interest in all fields of urology. The journal strives to provide publication of important manuscripts to the widest possible audience worldwide, without the constraints of expensive, hard-to-access, traditional bound journals. Advances in Urology is designed to improve publication access of both well-established urologic scientists and less well-established writers, by allowing interested scientists worldwide to participate fully.

Topics Covered (Recognized by AI)
Medicine99.6%Internal medicine90.3%Biology89.5%Surgery74.8%Genetics66%Pathology61.6%Urology48.9%Anatomy47.4%Endocrinology44.1%Cancer42.5%Radiology38.4%Chemistry29.1%Psychology28.5%Mathematics26.6%Biochemistry24.3%Urinary system22.7%Psychiatry21.4%Physics20.8%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

UROLOGY & NEPHROLOGY

Q4
Rank120/134
IndexESCI
JCIESCI2026

UROLOGY & NEPHROLOGY

Q3
Rank83/134
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF0.6
Articles / Year39
Total Citations0
2025
IF2.3
Articles / Year11
Total Citations11
2024
IF1.8
Articles / Year12
Total Citations24
2023
IF1.4
Articles / Year5
Total Citations14
2022
IF—
Articles / Year16
Total Citations160

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #17,535Scopus Q3SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.29

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
0.47

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,940 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations39
3-Year Documents30
Citable Documents30

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate17.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Obstetrics and GynecologyQ3
UrologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区UROLOGY & NEPHROLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Advances in Urology (ISSN: 1687-6369) is a peer-reviewed international scholarly journal in the field of UROLOGY & NEPHROLOGY, published by Hindawi Limited in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 0.60, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.290 (Q3), an H-index of 42.

The journal enforces rigorous peer evaluation with an annual output of approximately 14 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $2,940 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Hindawi Limited
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 9464d667-e090-4fd9-ac44-13deff63e40a
Database Updated: 2026-10-01